Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The COVID-19 pandemic has broadly disrupted biomedical treatment and research including non-invasive brain stimulation (NIBS). Moreover, the rapid onset of societal disruption and evolving regulatory restrictions may not have allowed for systematic planning of how clinical and research work may continue throughout the pandemic or be restarted as restrictions are abated. The urgency to provide and develop NIBS as an intervention for diverse neurological and mental health indications, and as a catalyst of fundamental brain research, is not dampened by the parallel efforts to address the most life-threatening aspects of COVID-19; rather in many cases the need for NIBS is heightened including the potential to mitigate mental health consequences related to COVID-19. OBJECTIVE: To facilitate the re-establishment of access to NIBS clinical services and research operations during the current COVID-19 pandemic and possible future outbreaks, we develop and discuss a framework for balancing the importance of NIBS operations with safety considerations, while addressing the needs of all stakeholders. We focus on Transcranial Magnetic Stimulation (TMS) and low intensity transcranial Electrical Stimulation (tES) - including transcranial Direct Current Stimulation (tDCS) and transcranial Alternating Current Stimulation (tACS). METHODS: The present consensus paper provides guidelines and good practices for managing and reopening NIBS clinics and laboratories through the immediate and ongoing stages of COVID-19. The document reflects the analysis of experts with domain-relevant expertise spanning NIBS technology, clinical services, and basic and clinical research - with an international perspective. We outline regulatory aspects, human resources, NIBS optimization, as well as accommodations for specific demographics. RESULTS: A model based on three phases (early COVID-19 impact, current practices, and future preparation) with an 11-step checklist (spanning removing or streamlining in-person protocols, incorporating telemedicine, and addressing COVID-19-associated adverse events) is proposed. Recommendations on implementing social distancing and sterilization of NIBS related equipment, specific considerations of COVID-19 positive populations including mental health comorbidities, as well as considerations regarding regulatory and human resource in the era of COVID-19 are outlined. We discuss COVID-19 considerations specifically for clinical (sub-)populations including pediatric, stroke, addiction, and the elderly. Numerous case-examples across the world are described. CONCLUSION: There is an evident, and in cases urgent, need to maintain NIBS operations through the COVID-19 pandemic, including anticipating future pandemic waves and addressing effects of COVID-19 on brain and mind. The proposed robust and structured strategy aims to address the current and anticipated future challenges while maintaining scientific rigor and managing risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lai, J., Ma, S., Wang, Y., Cai, Z., Hu, J., Wei, N., Wu, J., Du, H., Chen, T., Li, R., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.3976 · Cited by 8,015
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
The psychological impact of the COVID-19 epidemic on college students in China
Cao, W., Fang, Z., Hou, G., Han, M., Xu, X., Dong, J., & Zheng, J. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112934 · Cited by 5,843 · cited 6×
“M. Bikson et al. / Brain Stimulation 13 (2020) 1124e1149 1125 ah First Pavlov State Medical University, V. M. Bekhterev National Research Medical Center for Psychiatry and Neurology, St. Petersburg, Russia ai Department of Humanities Studies, University Federico II, Naples, Italy aj Aphasia Research Lab, IRCCS Santa L…”
BackgroundInfluentialPersistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.
Kampf, G., Todt, D., Pfaender, S., & Steinmann, E. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.01.022 · Cited by 3,796
Huang, Y., & Zhao, N. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112954 · Cited by 3,736
Mental health problems and social media exposure during COVID-19 outbreak
Gao, J., Zheng, P., Jia, Y., Chen, H., Mao, Y., Chen, S., Wang, Y., Fu, H., & Dai, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231924 · Cited by 2,830
Mental Health Problems and Social Media Exposure During COVID-19 Outbreak
Gao, J., Zheng, P., Jia, Y., Chen, H., Mao, Y., Chen, S., Wang, Y., Fu, H., & Dai, J. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541120 · Cited by 2,830
Wang, C., Pan, R., Wan, X., Tan, Y., Xu, L., McIntyre, R. S., Choo, F. N., Tran, B., Ho, R., Sharma, V. K., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.028 · Cited by 2,571
Lefaucheur, J.-P., Aleman, A., Baeken, C., Benninger, D. H., Brunelin, J., Di Lazzaro, V., Filipović, S. R., Grefkes, C., Hasan, A., Hummel, F. C., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.002 · Cited by 2,382
Self-citationLefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
Self-citationRisk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J., Li, Q., Jiang, C., Zhou, Y., Liu, S., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.021 · Cited by 2,074
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
Moriguchi, T., Harii, N., Goto, J., Harada, D., Sugawara, H., Takamino, J., Ueno, M., Sakata, H., Kondo, K., Myose, N., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.062 · Cited by 2,024
Shigemura, J., Ursano, R. J., Morganstein, J. C., Kurosawa, M., & Benedek, D. M. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12988 · Cited by 1,959
Suicide risk and prevention during the COVID-19 pandemic
Gunnell, D., Appleby, L., Arensman, E., Hawton, K., John, A., Kapur, N., Khan, M., O'Connor, R. C., Pirkis, J., Appleby, L., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30171-1 · Cited by 1,513 · cited 2×
“Sleep disturbances, somatization, stress-related illnesses, post-traumatic stress disorder (PTSD), anxiety disorders, depressive disorders and health risk behaviors such as social isolation, substance abuse or suicide attempts might also surge [2,15,102].”
BackgroundCOVID-19 transforms health care through telemedicine: Evidence from the field
Mann, D. M., Chen, J., Chunara, R., Testa, P. A., & Nov, O. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa072 · Cited by 1,361 · cited 1×
“The virtual visits operate directly through Epic [52] and is now system-wide throughout the NYU Langone Health system for implementation of telemedicine.”
MethodLong-term psychiatric morbidities among SARS survivors
Mak, I. W. C., Chu, C. M., Pan, P. C., Yiu, M. G. C., & Chan, V. L. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.03.001 · Cited by 1,018
Troyer, E. A., Kohn, J. N., & Hong, S. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.027 · Cited by 964 · cited 1×
“Moreover, a further wave of mental health issues following this first outbreak of this virus is anticipated [10,11].”
BackgroundInfluentialMental health services for older adults in China during the COVID-19 outbreak
Yang, Y., Li, W., Zhang, Q., Zhang, L., Cheung, T., & Xiang, Y.-T. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30079-1 · Cited by 857
Wang, H., Li, T., Barbarino, P., Gauthier, S., Brodaty, H., Molinuevo, J. L., Xie, H., Sun, Y., Yu, E., Tang, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30755-8 · Cited by 562
Mental health care for international Chinese students affected by the COVID-19 outbreak
Zhai, Y., & Du, X. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30089-4 · Cited by 454 · cited 1×
“Maintaining group cohesion is vital and implementing explicit support structures is necessary, particularly for those isolating on their own with families elsewhere [14].”
BackgroundMutz, J., Vipulananthan, V., Carter, B., Hurlemann, R., Fu, C. H. Y., & Young, A. H. (2019) · BMJ · doi:10.1136/bmj.l1079 · Cited by 427 · cited 2×
“Specifically for major depressive disorder, controlled trials [73e75], meta-analysis [68,76,77] and expert consensus [78] suggest tDCS is comparably effective with significantly less adverse events than drug therapy.”
BackgroundBrunoni, A. R., Moffa, A. H., Fregni, F., Palm, U., Padberg, F., Blumberger, D. M., Daskalakis, Z. J., Bennabi, D., Haffen, E., Alonzo, A., et al. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.164715 · Cited by 414
Self-citationGaynes, B. N., Lloyd, S. W., Lux, L., Gartlehner, G., Hansen, R. A., Brode, S., Jonas, D. E., Evans, T. S., Viswanathan, M., & Lohr, K. N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08815 · Cited by 347 · cited 1×
“range of neurological and psychiatric disorders [1e7], often on moderately or even severely impaired patients unresponsive to conventional therapies [8,9], the reestablishment of NIBS operations in the current era of COVID-19 pandemic as well as through future epidemics is of paramount importance.”
BackgroundRadiology Department Preparedness for COVID-19: Radiology Scientific Expert Review Panel
Mossa-Basha, M., Meltzer, C. C., Kim, D. C., Tuite, M. J., Kolli, K. P., & Tan, B. S. (2020) · Radiology · doi:10.1148/radiol.2020200988 · Cited by 324
Helmich, R. C., & Bloem, B. R. (2020) · Journal of Parkinson's Disease · doi:10.3233/jpd-202038 · Cited by 300
PTSD as the second tsunami of the SARS-Cov-2 pandemic
Dutheil, F., Mondillon, L., & Navel, V. (2021) · Psychological Medicine · doi:10.1017/s0033291720001336 · Cited by 286 · cited 1×
“Moreover, a further wave of mental health issues following this first outbreak of this virus is anticipated [10,11].”
BackgroundInfluentialShanthanna, H., Strand, N. H., Provenzano, D. A., Lobo, C. A., Eldabe, S., Bhatia, A., Wegener, J., Curtis, K., Cohen, S. P., & Narouze, S. (2020) · Anaesthesia · doi:10.1111/anae.15076 · Cited by 218
High-dose spaced Theta-burst TMS as a rapid-acting antidepressant in highly refractory depression
Williams, N. R., Sudheimer, K. D., Bentzley, B. S., Pannu, J., Stimpson, K. H., Duvio, D., Cherian, K., Hawkins, J., Scherrer, K. H., Vyssoki, B., et al. (2018) · Brain · doi:10.1093/brain/awx379 · Cited by 215
Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression
Holtzheimer, P. E., McDonald, W. M., Mufti, M., Kelley, M. E., Quinn, S., Corso, G., & Epstein, C. M. (2010) · Depression and Anxiety · doi:10.1002/da.20731 · Cited by 204
Nejati, V., Salehinejad, M. A., Nitsche, M. A., Najian, A., & Javadi, A.-H. (2020) · Journal of Attention Disorders · doi:10.1177/1087054717730611 · Cited by 163
Transcranial direct current stimulation in psychiatric disorders
Tortella, G. (2015) · World Journal of Psychiatry · doi:10.5498/wjp.v5.i1.88 · Cited by 154 · cited 1×
“Specifically for major depressive disorder, controlled trials [73e75], meta-analysis [68,76,77] and expert consensus [78] suggest tDCS is comparably effective with significantly less adverse events than drug therapy.”
Background
Cited by
Rossi, S., Antal, A., Bestmann, S., Bikson, M., Brewer, C., Brockmöller, J., Carpenter, L. L., Cincotta, M., Chen, R., Daskalakis, J. D., et al. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.10.003 · Cited by 1,573
“This issue was not discussed at the Consensus Conference but has emerged as important since; a detailed and timely discussion on this topic can be found in a recent review (Bikson et al., 2020).”
Self-citationCOVID-19 transforms health care through telemedicine: Evidence from the field
Mann, D. M., Chen, J., Chunara, R., Testa, P. A., & Nov, O. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa072 · Cited by 1,361
Setti, L., Passarini, F., De Gennaro, G., Barbieri, P., Perrone, M. G., Borelli, M., Palmisani, J., Di Gilio, A., Piscitelli, P., & Miani, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17082932 · Cited by 670
Nejati, V., Salehinejad, M. A., Nitsche, M. A., Najian, A., & Javadi, A.-H. (2020) · Journal of Attention Disorders · doi:10.1177/1087054717730611 · Cited by 163
Prefrontal tDCS modulates autonomic responses in COVID-19 inpatients
Pinto, T. P., Inácio, J. C., de Aguiar, E., Ferreira, A. S., Sudo, F. K., Tovar-Moll, F., & Rodrigues, E. C. (2023) · Brain Stimulation · doi:10.1016/j.brs.2023.03.001 · Cited by 11
“In addition, strict adherence to the appropriate collection, biosafety, and personal protective equipment protocols were adopted [26].”
Metadata
- Authors
- Bikson, M., Hanlon, C. A., Woods, A. J., Gillick, B. T., Charvet, L., Lamm, C., Madeo, G., Holczer, A., Almeida, J., Antal, A., Ay, M. R., Baeken, C., Blumberger, D. M., Campanella, S., Camprodon, J. A., Christiansen, L., Loo, C., Crinion, J. T., Fitzgerald, P., Gallimberti, L., Ghobadi-Azbari, P., Ghodratitoostani, I., Grabner, R. H., Hartwigsen, G., Hirata, A., Kirton, A., Knotkova, H., Krupitsky, E., Marangolo, P., Nakamura-Palacios, E. M., Potok, W., Praharaj, S. K., Ruff, C. C., Schlaug, G., Siebner, H. R., Stagg, C. J., Thielscher, A., Wenderoth, N., Yuan, T.-F., Zhang, X., & Ekhtiari, H.
- Venue
- Brain Stimulation
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 13
- Issue
- 4
- Pages
- 1124-1149
- ISSN
- 1876-4754 (ISSN-L)
- 1935-861X
- OpenAlex
- W3025280642
- Cited by
- 123
- References
- 31
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.